Home
>
National Drug Code (NDC)
>
Butalbital, Aspirin and Caffeine
Butalbital, Aspirin and Caffeine - 55289-040-20 - (Butalbital, Aspirin and Caffeine)
Drug Information of Butalbital, Aspirin and Caffeine
| Product NDC: | 55289-040 |
| Proprietary Name: | Butalbital, Aspirin and Caffeine |
| Non Proprietary Name: | Butalbital, Aspirin and Caffeine |
| Active Ingredient(s): | 325; 50; 40 mg/1; mg/1; mg/1 & nbsp; Butalbital, Aspirin and Caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Butalbital, Aspirin and Caffeine
| Product NDC: | 55289-040 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA086162 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19790605 |
Package Information of Butalbital, Aspirin and Caffeine
| Package NDC: | 55289-040-20 |
| Package Description: | 20 TABLET in 1 BOTTLE, PLASTIC (55289-040-20) |
NDC Information of Butalbital, Aspirin and Caffeine
| NDC Code | 55289-040-20 |
| Proprietary Name | Butalbital, Aspirin and Caffeine |
| Package Description | 20 TABLET in 1 BOTTLE, PLASTIC (55289-040-20) |
| Product NDC | 55289-040 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Butalbital, Aspirin and Caffeine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19790605 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ASPIRIN; BUTALBITAL; CAFFEINE |
| Strength Number | 325; 50; 40 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
